Recombinant Haemophilus influenzae Probable intracellular septation protein A (NTHI0991)

How does NTHI0991 compare to similar proteins in other bacterial species?

Septation proteins are conserved across many bacterial species as they are involved in the fundamental process of cell division. NTHI0991, as a probable intracellular septation protein, shares homology with other septation proteins in gram-negative bacteria.

Methodology for comparison:

• Perform sequence alignment using tools like BLAST or Clustal Omega to identify homologs

• Compare protein domains and motifs using InterPro or SMART

• Analyze protein structure predictions using AlphaFold or similar tools

• Create phylogenetic trees to visualize evolutionary relationships

NTHI0991 can be compared to proteins with similar functions in other respiratory pathogens such as Moraxella catarrhalis and Streptococcus pneumoniae to identify conserved regions that may be essential for function .

What is known about the expression pattern of NTHI0991 during different growth phases?

• qRT-PCR to measure mRNA expression levels at different growth stages

• Western blotting with anti-NTHI0991 antibodies to detect protein levels

• Reporter gene assays (e.g., using GFP fusions) to monitor expression in real-time

• RNA-seq to analyze transcriptomic profiles at different growth stages

Like other septation proteins, NTHI0991 expression may increase during active cell division phases. Unlike surface-exposed proteins such as EF-Tu, which has been well-characterized in H. influenzae , intracellular proteins like NTHI0991 may have more consistent expression patterns regardless of the host environment.

What are the optimal conditions for expressing recombinant NTHI0991 protein?

For optimal expression of recombinant NTHI0991:

• Expression system selection:

  • E. coli BL21(DE3) is commonly used for recombinant protein expression

  • Consider codon optimization for E. coli if expression yields are low

• Vector considerations:

  • Use vectors with strong inducible promoters (e.g., T7)

  • Include appropriate tags (His-tag, GST) for purification

  • Signal peptide analysis should be performed since this appears to be a membrane protein

• Expression conditions:

  • Induction at OD600 of 0.6-0.8

  • IPTG concentration: 0.1-1.0 mM

  • Post-induction growth at lower temperatures (16-25°C) to improve protein folding

  • Consider using specialized media (e.g., auto-induction media)

• Purification strategy:

  • Membrane protein extraction may require detergents

  • Affinity chromatography based on the chosen tag

  • Size exclusion chromatography for final purification

Similar approaches have been successful for other H. influenzae proteins as seen in the EF-Tu studies .

How can researchers validate the function of NTHI0991 in cell division processes?

Functional validation approaches:

• Gene knockout/knockdown:

  • Create NTHI0991 deletion mutants using homologous recombination

  • Analyze cell morphology and division rates

  • Complement the mutation to confirm phenotype rescue

• Fluorescence microscopy:

  • GFP-tagging of NTHI0991 to visualize localization during cell division

  • Time-lapse imaging to track protein dynamics during septation

  • Co-localization with other known division proteins (FtsZ, MinC, etc.)

• Protein-protein interaction studies:

  • Bacterial two-hybrid assays to identify interaction partners

  • Co-immunoprecipitation followed by mass spectrometry

  • Surface plasmon resonance to quantify binding affinities

• Cell division assays:

  • Growth curve analysis of wild-type vs. mutant strains

  • Microscopy-based septation analyses

  • Cell synchronization experiments to study division-specific events

These methodologies would help establish NTHI0991's role in bacterial cell division, similar to approaches used for studying other intracellular bacterial processes in H. influenzae .

What methodologies are recommended for studying NTHI0991 during host cell infection?

To study NTHI0991 during host cell infection:

• Infection models:

  • Human respiratory epithelial cell lines (e.g., A549, BEAS-2B)

  • Primary human bronchial epithelial cells grown at air-liquid interface

  • Mouse infection models for in vivo studies

• Protein expression analysis:

  • qRT-PCR to measure NTHI0991 expression during different infection stages

  • Western blot using cell fractionation to separate bacterial and host proteins

  • Immunofluorescence microscopy with specific antibodies

• Functional studies during infection:

  • Compare wild-type and NTHI0991 mutant strains in:

    • Invasion assays (gentamicin protection assay)

    • Intracellular survival kinetics

    • Host cell response measurements (cytokine production, etc.)

• Trafficking studies:

  • Combine fluorescently labeled bacteria with markers of host cell compartments

  • Live-cell imaging to track bacterial movement within host cells

  • Correlative light and electron microscopy for ultrastructural details

This approach builds on established methods used for studying NTHi invasion and intracellular survival in host respiratory cells .

How might NTHI0991 contribute to H. influenzae pathogenicity and intracellular survival?

While direct evidence for NTHI0991's role in pathogenicity is limited, several research directions can be explored:

• Potential roles based on septation function:

  • Proper cell division is essential for bacterial fitness during infection

  • Disruption may affect growth rates within host cells

  • May influence bacterial morphology, potentially affecting host recognition

• Comparison with other pathogens:

  • Septation proteins in other bacteria have been linked to stress resistance

  • Some division proteins are repurposed during infection to promote survival

• Intracellular environment adaptation:

  • H. influenzae is known to invade epithelial cells and survive intracellularly

  • Cell division regulation may be critical for establishing persistent infections

  • May coordinate with stress response systems during intracellular residence

• Experimental approaches to test pathogenicity contributions:

  • Animal infection models comparing wild-type vs. NTHI0991 mutants

  • Competition assays between strains

  • Transcriptomic profiling during infection to identify co-regulated virulence factors

Unlike surface-exposed proteins such as EF-Tu that directly interact with host components , intracellular proteins like NTHI0991 would likely contribute to pathogenicity through maintaining bacterial physiological processes during infection.

What is the relationship between NTHI0991 and other known virulence factors in H. influenzae?

Research methodologies to explore these relationships:

• Genetic interaction studies:

  • Create double mutants (NTHI0991 + known virulence factor)

  • Analyze epistatic effects on virulence phenotypes

  • Transposon-sequencing (Tn-seq) to identify genetic interactions

• Transcriptomic approaches:

  • RNA-seq comparing NTHI0991 mutants vs. wild-type

  • Identify co-regulated genes in different infection conditions

  • ChIP-seq if transcriptional regulation is suspected

• Proteomic analyses:

  • Compare protein expression profiles between strains

  • Identify protein-protein interactions via pull-down assays

  • Analyze post-translational modifications

• Functional correlation studies:

  • Compare phenotypes with known virulence pathways:

    • IgA1 protease expression and function

    • Adhesin (e.g., Hap) activity

    • Invasion and intracellular trafficking

While EF-Tu has been shown to moonlight as a surface protein that can be targeted by bactericidal antibodies , NTHI0991's intracellular location suggests different virulence mechanisms, possibly related to optimizing bacterial replication during intracellular stages of infection.

How can structural studies of NTHI0991 inform drug development strategies?

Advanced structural biology approaches for NTHI0991:

• Protein structure determination:

  • X-ray crystallography (challenging for membrane proteins)

  • Cryo-electron microscopy for larger complexes

  • NMR for smaller domains or fragments

  • Computational structure prediction (AlphaFold2)

• Structure-based drug design process:

  • Identify potential binding pockets through computational analysis

  • Virtual screening of compound libraries against the structure

  • Fragment-based approaches to develop lead compounds

  • Molecular dynamics simulations to understand protein flexibility

• Experimental validation:

  • Thermal shift assays to confirm compound binding

  • Surface plasmon resonance for binding kinetics

  • Activity assays to confirm functional inhibition

  • Crystallization of protein-inhibitor complexes

• Design considerations specific to septation proteins:

  • Focus on conserved active sites across bacterial species

  • Target regions unique to bacterial septation (not present in humans)

  • Consider membrane accessibility of binding sites

  • Evaluate essentiality through gene knockout studies

Unlike surface proteins that can be targeted by antibodies, intracellular proteins like NTHI0991 would require small molecule inhibitors capable of penetrating the bacterial cell envelope, presenting both challenges and opportunities for novel antimicrobial development .

What are the challenges in developing antibodies against NTHI0991 for research applications?

Challenges and methodological solutions:

• Protein expression and purification challenges:

  • Membrane protein solubility issues

  • Solution: Use detergent solubilization or membrane-mimetic systems

  • Alternative: Express soluble domains separately

• Antibody generation strategies:

  • Select antigenic peptides using epitope prediction tools

  • Consider peptide synthesis for difficult regions

  • Use multiple hosts (rabbit, mouse, chicken) for diverse antibody repertoires

  • Validate with Western blot, immunoprecipitation, and immunofluorescence

• Cross-reactivity considerations:

  • Test against related proteins from other Haemophilus species

  • Validate with knockout strains as negative controls

  • Pre-adsorb antibodies against related proteins if necessary

• Application-specific optimization:

  • For flow cytometry: optimize fixation/permeabilization

  • For immunoelectron microscopy: validate specific labeling conditions

  • For immunofluorescence: determine optimal fixation methods

Unlike EF-Tu, which has been successfully used to raise antibodies that recognize surface-exposed epitopes , NTHI0991 antibodies would primarily be useful for research applications requiring cell permeabilization to access the intracellular protein.

How can systems biology approaches integrate NTHI0991 into broader understanding of H. influenzae adaptation during infection?

Systems biology methodologies:

• Multi-omics integration:

  • Combine transcriptomics, proteomics, and metabolomics data

  • Develop network models of protein-protein interactions

  • Use computational modeling to predict system perturbations

  • Data collection at multiple infection timepoints

• Network analysis techniques:

  • Construct protein interaction networks

  • Identify hubs and bottlenecks in metabolic pathways

  • Compare networks between commensal and pathogenic states

  • Use graph theory to identify critical nodes

• Experimental validation of predictions:

  • CRISPR interference for temporal gene regulation

  • Targeted metabolomics to validate predicted metabolic shifts

  • Fluorescent reporters to track network dynamics in real-time

  • Single-cell approaches to capture population heterogeneity

• Comparative systems approaches:

  • Compare response networks across different H. influenzae strains

  • Analyze system differences between encapsulated and non-encapsulated strains

  • Contrast with other respiratory pathogens like M. catarrhalis

This systems biology framework would place NTHI0991 within the broader context of H. influenzae adaptation during host invasion and intracellular survival, complementing the more targeted studies of individual virulence factors and invasion mechanisms described in the literature .